VLG.L

Venture Life Group Plc
Venture Life Group - Director/PDMR Shareholding
30th October 2024, 10:58
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2493K
Venture Life Group PLC
30 October 2024
 

30 October 2024

 

A logo with orange circles Description automatically generated

 

VENTURE LIFE GROUP PLC

("Venture Life", "VLG" or the "Group")

 

Director/PDMR Shareholding

 

Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, announces that Mark Adams, Non-Executive Director, has today purchased 116,496 ordinary shares of 0.3p each in the Company ("Ordinary Shares") at a volume weighted average price of 42.79 pence per Ordinary Share.

 

Following this purchase, Mr Adams beneficially holds 175,000 Ordinary Shares representing approximately 0.14 per cent. of the Company's issued share capital.

 

For further information, please contact:

 

Venture Life Group PLC

+44 (0) 1344 578004

Jerry Randall, Chief Executive Officer

Daniel Wells, Chief Financial Officer


 

Cavendish Capital Markets Limited (Nomad and Broker)

 

+44 (0) 20 7397 8900

Michael Johnson (Sales)

Stephen Keys / Camilla Hume (Corporate Finance)

 

 



 

 


About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Activ range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, Earol for ear wax removal, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worldwide.

 

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the Company to retailers, elsewhere they are supplied by the Group's international distribution partners. 

 

Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mark Adams

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Venture Life Group plc

b)

 

LEI

 

213800S8CZUPLAB2KC70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

 

Ordinary Shares of 0.3p each in Venture Life Group plc

 

 

 

GB00BFPM8908

b)

 

Nature of the transaction

 

Purchase of ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price

Volume

42.8056p

58,403

42.85p

23,337

42.48p

14,756

43.0p

5,000

42.9p

5,000

42.9p

5,000

42.9p

5,000



d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

See above

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

30 October 2024

f)

 

Place of the transaction

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEIIRLIVIS]]>
TwitterFacebookLinkedIn